IntelGenx Technologies Stock Forecast, Price & News

IntelGenx Technologies (OTCMKTS:IGXT) Frequently Asked Questions

What stocks does MarketBeat like better than IntelGenx Technologies?

Wall Street analysts have given IntelGenx Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but IntelGenx Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting IntelGenx Technologies?

IntelGenx Technologies saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 27,700 shares, an increase of 31.3% from the September 15th total of 21,100 shares. Based on an average trading volume of 230,000 shares, the short-interest ratio is presently 0.1 days.
View IntelGenx Technologies' Short Interest.

When is IntelGenx Technologies' next earnings date?

IntelGenx Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for IntelGenx Technologies.

How were IntelGenx Technologies' earnings last quarter?

IntelGenx Technologies Corp. (OTCMKTS:IGXT) posted its quarterly earnings data on Wednesday, August, 4th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.16 million for the quarter. IntelGenx Technologies had a negative net margin of 422.71% and a negative trailing twelve-month return on equity of 1,071.26%.
View IntelGenx Technologies' earnings history.

How has IntelGenx Technologies' stock been impacted by Coronavirus?

IntelGenx Technologies' stock was trading at $0.3950 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IGXT shares have increased by 44.3% and is now trading at $0.57.
View which stocks have been most impacted by COVID-19.

Who are IntelGenx Technologies' key executives?

IntelGenx Technologies' management team includes the following people:

• Horst G. Zerbe, Chairman & Chief Executive Officer
• André Godin, President & Chief Financial Officer
• Rodolphe Obeid, Chief Operating Officer
• Nadine Paiement, Vice President-Research & Development
• Dana Matzen, Vice President-Business & Corporate Development

Who are some of IntelGenx Technologies' key competitors?

Some companies that are related to IntelGenx Technologies include Avalo Therapeutics (AVTX), Oncorus (ONCR), Puma Biotechnology (PBYI), Terns Pharmaceuticals (TERN), Frequency Therapeutics (FREQ), Ovid Therapeutics (OVID), Paratek Pharmaceuticals (PRTK), NextCure (NXTC), Viracta Therapeutics (VIRX), Tricida (TCDA), Matinas BioPharma (MTNB), Kamada (KMDA), Infinity Pharmaceuticals (INFI), Sensei Biotherapeutics (SNSE) and Seelos Therapeutics (SEEL).
View all of IGXT's competitors.

What other stocks do shareholders of IntelGenx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include Cronos Group (CRON), KemPharm (KMPH), Exelixis (EXEL), SemiLEDs (LEDS), New Residential Investment (NRZ), Anavex Life Sciences (AVXL), Ampio Pharmaceuticals (AMPE), BioDelivery Sciences International (BDSI), BIOLASE (BIOL) and Ocugen (OCGN).

What is IntelGenx Technologies' stock symbol?

IntelGenx Technologies trades on the OTCMKTS under the ticker symbol "IGXT."

How do I buy shares of IntelGenx Technologies?

Shares of IGXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IntelGenx Technologies' stock price today?

One share of IGXT stock can currently be purchased for approximately $0.57.

How much money does IntelGenx Technologies make?

IntelGenx Technologies has a market capitalization of $63.84 million and generates $1.54 million in revenue each year. The company earns $-7.04 million in net income (profit) each year or ($0.07) on an earnings per share basis.

How many employees does IntelGenx Technologies have?

IntelGenx Technologies employs 4 workers across the globe.

What is IntelGenx Technologies' official website?

The official website for IntelGenx Technologies is www.intelgenx.com.

Where are IntelGenx Technologies' headquarters?

IntelGenx Technologies is headquartered at 6420 ABRAMS, VILLE SAINT LAURENT A8, H4S 1Y2.

How can I contact IntelGenx Technologies?

IntelGenx Technologies' mailing address is 6420 ABRAMS, VILLE SAINT LAURENT A8, H4S 1Y2. The company can be reached via phone at (514) 331-7440 or via email at [email protected].